Click on each image below to explore the studies I’ve worked on.
The LightBAR study is part of the Lighthouse Consortium on Obesity Management (LightCOM), a collaborative research initiative between Denmark and the UK. This randomized controlled trial compares the effectiveness of an intensive, non-surgical weight loss program to bariatric surgery in adults with severe and complex obesity. The study aims to assess not only weight loss outcomes but also improvements in physical and mental health, utilizing innovative digital health technologies to support participants.
At the hospital, I helped support this study through patient recruitment, screening, and data entry, contributing to research exploring alternative approaches to obesity treatment and potential pathways beyond surgical intervention.
The IBD BioResource is a national platform designed to expedite research into Crohn’s disease and ulcerative colitis by building a panel of 50,000 recallable patients with detailed genetic and clinical data. This initiative aims to uncover the causes of IBD, predict disease progression, and develop better-targeted treatments.
I supported this study through ongoing recruitment and data collection, helping to build a valuable resource for future research. It was rewarding to be involved in a project that could directly impact how IBD is understood, managed, and treated in the years to come.
PANACEA is an observational study investigating whether a simple exhaled breath test can help detect gastrointestinal cancers—including oesophageal, stomach, pancreatic, liver, and bowel cancers—at an earlier stage. By analysing tiny molecules present in breath samples, researchers hope to identify reliable biomarkers that could support faster diagnosis, improve referral pathways, and ultimately increase opportunities for earlier treatment.
I supported this study through participant recruitment, preparing and operating the breath collection equipment, collecting and processing breath samples, and ensuring accurate data collection throughout each study visit. It was rewarding to contribute to research exploring non-invasive diagnostic technologies that have the potential to improve early cancer detection and enhance the patient experience.